Vivani Medical, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Vivani Medical, Inc. (VANI) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $2.41 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.41M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.99M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.54M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.50M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $2.41M 10-K · filed 2026-03-26 |
| 2024-12-31 | $1.99M 10-K · filed 2026-03-26 |
| 2023-12-31 | $1.54M 10-K · filed 2025-03-31 |
| 2022-12-31 | $1.50M 10-K · filed 2024-03-26 |
| 2021-12-31 | $401.00K 10-K · filed 2022-03-29 |
| 2020-12-31 | $380.00K 10-K · filed 2022-03-29 |
| 2019-12-31 | $4.64M 10-K · filed 2021-03-16 |
| 2018-12-31 | $4.30M 10-K · filed 2020-03-19 |
| 2017-12-31 | $3.35M 10-K · filed 2019-03-19 |
| 2016-12-31 | $4.13M 10-K · filed 2018-03-20 |
| 2015-12-31 | $2.83M 10-K · filed 2017-03-16 |
| 2014-12-31 | $2.49M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |